Business / Finance

RSS
TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

Optibrium appoints Steve Yemm as Chief Commercial Officer

Optibrium appoints Steve Yemm as Chief Commercial Officer

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Andor Launches New ZL41 Cell and Sona sCMOS Cameras

Andor Launches New ZL41 Cell and Sona sCMOS Cameras

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Porous PTFE components for demanding applications

Porous PTFE components for demanding applications

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support

H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support

Healthcare super fund HESTA directly invests in Inventia Life Science

Healthcare super fund HESTA directly invests in Inventia Life Science

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.